Bvffpartners.com

Bvffpartners.com has Server used 143.95.73.224 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2014-11-07 (6 years, 323 days) and hosted in Los Angeles United States, server ping response time 43 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Bvffpartners keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Bvff partners
2 Bvff partners llc
3 Bvf partners
4 Bvf partners 13f
5 Bvf partners l.p
6 Bvf partners holdings
7 Bvf partners portfolio
8 Bvf partners investments
9 Bvf partners arman gupta

Hosting Provider

Website: Bvffpartners.com
Hostname: ip-143-95-73-224.iplocal
Country:
Region: CA
City: Los Angeles
Postal Code: 90014
Latitude: 34.043800354004
Longitude: -118.25119781494
Area Code: 213
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (15 hours ago)

   » Bobbyjonesband.com (2 day ago)

   » Huishoubao.com (19 hours ago)

   » M1file.com (1 day ago)

   » Renhomesantalya.com (14 day ago)

   » Napadrivertours.com (2 day ago)

Results For Websites Listing

Found 48 Websites with content related to this domain, It is result after search with search engine

BVFF Partners Oklahoma's Premier Business Valuation Resource

Bvffpartners.com   DA: 16 PA: 16 MOZ Rank: 32

  • We provide business valuation services for estate and gift tax purposes, marital dissolution, business litigation, and transactions
  • However, the expertise we have in business valuation allows us to assist our clients in other advisory services such as litigation support, forensic accounting, cash flow analysis, outsourced/virtual

BVF Partners L.P. San Francisco

Bvflp.com   DA: 9 PA: 9 MOZ Rank: 19

(415) 525-8800. 44 Montgomery Street 40th Floor San Francisco CA 94104 CONTACT US

BVF Partners Investor Profile: Portfolio & Exits PitchBook

Pitchbook.com   DA: 13 PA: 27 MOZ Rank: 42

  • BVF Partners General Information Description
  • Founded in 1993, BVF Partners is a fundamental equity hedge fund manager based in San Francisco, California
  • The firm primarily invests in companies operating in the biotechnology sector.

BVF Partners Portfolio Largest Holdings & Trades

Hedgefollow.com   DA: 15 PA: 19 MOZ Rank: 37

  • Top Holdings Largest Trades Portfolio Structure Sector Allocation Performance History

BVF Partners

Crunchbase.com   DA: 18 PA: 26 MOZ Rank: 48

  • is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
  • Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its

BVF Partners LP

Investingreview.org   DA: 19 PA: 21 MOZ Rank: 45

  • BVF Partners LP is legally known as BVF PARTNERS L.P.
  • This firm has 12 employees, of which 9 are employees in advisory roles
  • The number of clients served by it is unknown
  • The firm's last reported SEC (U.S
  • Securities and Exchange Commission) status is listed as “Approved”, with a registration date of Mar

BVF Partners LP

Bloomberg.com   DA: 17 PA: 28 MOZ Rank: 51

Company profile page for BVF Partners LP including stock price, company news, press releases, executives, board members, and contact information

Bvf Partners L P/il SEC Registration

Sec.report   DA: 10 PA: 15 MOZ Rank: 32

  • Bvf Partners L P/il is a regulated by the U.S
  • Security and Exchange Commission
  • This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Bvf Partners L P/il

Michael Murray

Linkedin.com   DA: 16 PA: 27 MOZ Rank: 51

  • Chris Dimitropoulos Managing Director, Biotechnology Investments (Private & Public) at FALCON EDGE CAPITAL, LP …

Forte Biosciences Inc

Fortebiorx.com   DA: 18 PA: 50 MOZ Rank: 77

  • “Forte’s transition to the public market is a significant milestone for us and serves as testament to the determination of our team and the support of our investors including Alger, ArrowMark, BVF Partners LP, OrbiMed and Franklin Templeton
  • We believe that the closing of the merger signifies a transformative event that will provide Forte with

Mark Lampert

Investforkidschicago.org   DA: 24 PA: 23 MOZ Rank: 57

  • Lampert is the founder and General Partner of BVF Partners L.P
  • (“BVF”), a San Francisco-based, private biotechnology investment firm established in 1993 that manages the Biotechnology Value Fund, L.P
  • Lampert has been active in the biotechnology industry since 1984, having served on the boards of directors of numerous public and Continue Reading

Nimbus Therapeutics Announces $105 Million Private

Nimbustx.com   DA: 16 PA: 50 MOZ Rank: 77

  • – Led by BVF Partners L.P., round included participation from new and existing investors – CAMBRIDGE, Mass
  • – July 13, 2021 – Nimbus Therapeutics , a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the closing of a $105 million private financing round.

BVF PARTNERS L P Top 13F Holdings

Whalewisdom.com   DA: 15 PA: 26 MOZ Rank: 53

  • BVF Partners L P is based out of San Francisco
  • Whalewisdom has at least 1 13D filings, and 73 Form 4 filings The firm has no submitted 13F filings …

MoonLake Immunotherapeutics Appoints Former Kymab CEO

Moonlaketx.com   DA: 18 PA: 18 MOZ Rank: 49

  • MoonLake Immunotherapeutics AG was founded in 2021, backed by a Series A financing led by BVF Partners L.P
  • Other shareholders include Merck KGaA, Darmstadt, Germany
  • The Company intends to accelerate the clinical development of Sonelokimab, an investigational IL-17A/IL-17F inhibitor, in several diseases in which over-expression of the

BVF Partners

Massinvestordatabase.com   DA: 24 PA: 15 MOZ Rank: 53

  • is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
  • Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its

BVF Partners Investment Information CipherBio

Cipherbio.com   DA: 17 PA: 31 MOZ Rank: 63

  • is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
  • Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of itsinvestments.

BVF INC Top 13F Holdings

Whalewisdom.com   DA: 15 PA: 17 MOZ Rank: 48

  • BVF is based out of San Francisco
  • BVF is a hedge fund with 5 clients and discretionary assets under management (AUM) of $4,734,418,837 (Form ADV from 2021-03-30).

Insider Trading

Secform4.com   DA: 16 PA: 28 MOZ Rank: 61

  • BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd
  • BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner: 189,651: $11.1: $2,104,785: 372,526 (Direct) View: 2020-09-15 Purchase: 2020-09-17 7:42 pm: Merus N.V

Janux Therapeutics Closes $125 Million Series B Financing

Januxrx.com   DA: 15 PA: 50 MOZ Rank: 83

Proceeds support advancement of the company’s pipeline of TRACTr drug candidates into clinical trials Funding round supported by top-tier crossover investor syndicate, including RA Capital Management, BVF Partners L.P., EcoR1 Capital, Janus Henderson Investors, Logos Capital, OrbiMed, Samsara BioCapital, Surveyor Capital, and other investors SAN DIEGO, April 20, 2021 – Janux Therapeutics

Alpine Raises $91M To Fuel The Seattle Biotech’s Clinical

Msn.com   DA: 11 PA: 50 MOZ Rank: 80

  • The current round of investment also included Decheng Capital, BVF Partners, TCG X, Avidity Partners, OrbiMed, Omega Fund, and Logos Capital
  • Alpine’s stock closed at $9.81 on Wednesday.

Biotechnology Value Fund

Crunchbase.com   DA: 18 PA: 38 MOZ Rank: 76

  • Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
  • Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while

Vancouver-based Alpha-9 Theranostics Announces $11 Million

Bctechnology.com   DA: 20 PA: 50 MOZ Rank: 91

  • Vancouver-based Alpha-9 Theranostics Announces $11 Million Series-A Financing to Advance Portfolio of Radiotherapeutics and Diagnostics
  • Vancouver, BC, May 4, 2021--Alpha-9 Theranostics Inc
  • announced an $11 million Series-A financing to advance a portfolio of novel radiotherapeutics and diagnostics
  • Longitude Capital led the financing with participation from BVF …

Bvf Partners L.P.

Corporationwiki.com   DA: 23 PA: 47 MOZ Rank: 92

  • filed as a Foreign in the State of California on Saturday, January 1, 1994 and is approximately twenty-seven years old, according to public records filed with California Secretary of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in.

BVF Partners

Zoominfo.com   DA: 16 PA: 28 MOZ Rank: 67

  • is a San Francisco-based private investment partnership specializing in fundamentally-driven public bi Read More
  • Headquarters: 44 Montgomery St, Fl 40, San Francisco, California, 94104, United States

BVF Partners LP

Relationshipscience.com   DA: 23 PA: 35 MOZ Rank: 82

  • BVF Partners pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies
  • The firm's investments within the biotechnology sector focus primarily on the securities of companies with market capitalizations of less than $1 billion
  • BVF may also invest in unregistered securi.

Rezolute Announces $41 Million Private Placement With

Rezolutebio.com   DA: 19 PA: 50 MOZ Rank: 94

  • Financing led by CAM Capital with Federated Hermes Kaufmann, Surveyor Capital, and BVF Partners participating
  • 09, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc
  • (OCTQB:RZLT), a clinical stage biopharmaceutical company dedicated to advancing therapies for rare, metabolic, and life-threatening diseases, announced today a $41 million private placement which is …

All Stocks Held By BVF Inc. IL

Holdingschannel.com   DA: 23 PA: 31 MOZ Rank: 80

  • IL Info: Size ($ in 1000's) At 06/30/2021: $2,668,191 At 03/31/2021: $2,667,271 Combined Holding Report Includes: BVF INC IL BVF PARTNERS L P IL
  • IL holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from BVF Inc

Bvf Partners L.P. In New York, NY Company Info & Reviews

Bizapedia.com   DA: 17 PA: 24 MOZ Rank: 68

  • is a New York Foreign Limited Partnership filed On January 13, 2020
  • The company's filing status is listed as Active and its File Number is 5687263
  • The Registered Agent on file for this company is Bvf Partners L.P
  • and is located at 44 Montgomery Street Suite …

BVF Inc. IL Top Holdings 13F Filings

Holdingschannel.com   DA: 23 PA: 29 MOZ Rank: 80

  • BVF Inc. IL Info: Size ($ in 1000's) At 06/30/2021: $2,668,191 At 03/31/2021: $2,667,271 Combined Holding Report Includes: BVF INC IL BVF PARTNERS L P IL
  • IL holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from BVF Inc

BVF INC Top 13F Holdings

Legacy.whalewisdom.com   DA: 22 PA: 17 MOZ Rank: 68

BVF is based out of San Francisco. BVF is a hedge fund with 5 clients and discretionary assets under management (AUM) of $4,734,418,837 (Form ADV from 2021-03-30).

Here’s Our Rant About Rain Therapeutics Inc. (RAIN) – News

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 94

BVF PARTNERS L P/IL, the Director of Rain Therapeutics Inc., purchase 121,986 shares at $15.94 during a trade that took place back on May 21, which means that BVF PARTNERS L P/IL is holding 940,581 shares at $1,944,701 based on the most recent closing price.

Gorjan Hrustanovic, Principal, BVF Partners

Topionetworks.com   DA: 21 PA: 50 MOZ Rank: 19

  • Gorjan is Principal at BVF Partners L.P., where he has been leading both public and private biotechnology investments since 2015
  • Prior to joining the BVF Partners L.P., Dr
  • Hrustanovic obtained his PhD in cancer biology & cell signaling at the University of California, San Francisco (UCSF), with a primary focus on precision medicine and resistance to targeted therapies in lung cancer.

BVF Partners LP · 44 Montgomery Street, 40th Floor, San

Opencorpdata.com   DA: 16 PA: 25 MOZ Rank: 73

  • BVF Partners LP (LEI# 254900GVYW8GU3J8RL14) is a legal entity registered with Bloomberg Finance L.P.
  • The address is 44 Montgomery Street, 40th Floor, San Francisco, US-CA, 94104, US.

Matthew D Perry, Bvf Partners LP: Profile And Biography

Bloomberg.com   DA: 17 PA: 23 MOZ Rank: 73

  • The Company invests in small-cap biotechnology companies
  • BVF Partners serves customers in the United States

BVF Partners LP AUM 13F

Aum13f.com   DA: 10 PA: 21 MOZ Rank: 65

  • Track the AUM, funds, and holdings for BVF Partners LP over time
  • View the latest funds and 13F holdings

SoftBank Makes Another Appearance, A TPG + EVBox Update

Spactrack.substack.com   DA: 22 PA: 36 MOZ Rank: 93

  • Also includes: Fidelity Management & Research Company LLC, Franklin Templeton, Invus, Rock Springs Capital, Bain Capital Life Sciences, BVF Partners L.P., Boxer Capital, LLC, Avidity Partners, Andreessen Horowitz (a16z), Verily, Mubadala Investment Company and its asset management subsidiary, Mubadala Capital

BVF PARTNERS L P IL: Form 4 Insider Trading History

Insiderinsights.com   DA: 23 PA: 36 MOZ Rank: 95

Free, legal insider trading data for BVF PARTNERS L P IL, a Director and BO of RAIN THERAPEUTICS INC (RAIN)

Michael Murray, Analyst, BVF Partners L.P.

Topionetworks.com   DA: 21 PA: 47 MOZ Rank: 13

  • Prior to joining the General Partner, Mr
  • Murray was an Associate at Leerink Swann in the strategy consulting division where he advised pharmaceutical and biotech clients on M&A strategy, due diligence, clinical development strategy, and commercial opportunity assessments.

Health Sciences To Combine With Immunovant SPACInsider

Spacinsider.com   DA: 15 PA: 50 MOZ Rank: 12

  • Health Sciences Acquisitions Corp., the RTW Investments-backed SPAC focused on the biopharma/med-tech sector, announced their merger this morning with Immunovant Sciences, Ltd
  • (“Immunovant”), a clinical-stage biopharmaceutical company focusing on autoimmune diseases.
  • Specifically, Immunovant is developing “IMVT-1401, a fully human anti-FcRn monoclonal antibody …

Vividion Therapeutics Raises $135M In Series C Funding

Precisiononcologynews.com   DA: 29 PA: 50 MOZ Rank: 11

  • The company's existing investors ARCH Venture Partners, BVF Partners, Casdin Capital, Mubadala Capital, Nextech Invest, and Versant Ventures also participated
  • "By leveraging our unique platform technologies, we are building a robust pipeline of precision oncology and immunology programs," Vividion CEO Jeffrey Hatfield said in a statement.

Press Release Distribution And Management

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 10

Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering with Participation by New Fundamental Healthcare Investors Acorn …

Matthew Perry Board Member CTI BioPharma Corp.

Cbc.gcs-web.com   DA: 15 PA: 27 MOZ Rank: 83

  • Perry has been one of our directors since January 2016
  • Perry is the President of BVF Partners L.P
  • and portfolio manager for the underlying funds managed by the firm
  • BVF Partners is a private investment partnership that has focused on small-cap, value oriented investment opportunities for more than 20 years.

Five Prime Therapeutics Inc. (FPRX) Reveals An Earnings

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 8

  • Reports are indicating that there were more than several insider trading activities at FPRX starting from BVF PARTNERS L P/IL, who sale 7,393,340 shares at the price of $20.19 back on Nov 11
  • After this action, BVF PARTNERS L P/IL now owns 81,263 shares of Five Prime Therapeutics Inc., valued at $149,247,137 using the latest closing price.

BVF PARTNERS LP: Form 4 Insider Trading History Insider

Insiderinsights.com   DA: 23 PA: 32 MOZ Rank: 98

Free, legal insider trading data for BVF PARTNERS L P IL, a Director and BO of RAIN THERAPEUTICS INC (RAIN)

Bvf Partners L.P.

Dandb.com   DA: 13 PA: 50 MOZ Rank: 6

  • is located at 1 Sansome St Fl 39 in San Francisco and has been in the business of Investors, Nec since 2007.

XOMA Announces Proposed Rights Offering :: XOMA

Investors.xoma.com   DA: 18 PA: 50 MOZ Rank: 5

BVF Partners L.P., the Company's largest shareholder, owning approximately 17.9% of the Company’s outstanding common stock (and 48.6% on an as-converted basis), will backstop the Rights Offering and has agreed to purchase up to $20 million of Series Y Preferred Stock at price of $13,000 per share in a private placement within five days of

Recently Analyzed Sites

Revo.com (15 hours ago)

Bobbyjonesband.com (2 day ago)

Huishoubao.com (19 hours ago)

M1file.com (1 day ago)

Renhomesantalya.com (14 day ago)

Trekksoft.com (14 hours ago)

Tibbo.com (5 day ago)

Dbatlanta.com (1 seconds ago)

Tailspinbandsc.com (3 day ago)

Dungscanada.com (4 day ago)

Jfsorange.org (3 day ago)

Marloweslu.com (6 day ago)